SEOUL, Jan 12 (Reuters) - South Korea has authorised use of Novavax Inc's COVID-19 vaccine, the food and drug safety ministry said on Wednesday.
It joins the ranks of authorised vaccines made by AstraZeneca Inc, Moderna Inc, Pfizer and Johnson & Johnson's Janssen.
(Reporting by Heekyong Yang and Joyce Lee; Editing by Clarence Fernandez)
Our Standards: The Thomson Reuters Trust Principles.
